Furthermore, studies have indicated that in hepatic steatosis, Ginsenoside Rb1 could activate mitochondrial β-oxidation functions and ameliorate fatty liver by regulating some key enzyme expression and CPT1A active.34 This evidence concerns the gene CPT1A and fatty liver disease.